NCI-60 Cell Line Screening: A Radical Departure in its Time.

NCI-60 Cell Line Screening: A Radical Departure in its Time.

Item
http://www.wikidata.org/entity/Q30383428
Transcription factor-associated combinatorial epigenetic pattern reveals higher transcriptional activity of TCF7L2-regulated intragenic enhancers.Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121).Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.HLBT-100: a highly potent anti-cancer flavanone from Tillandsia recurvata (L.) LCytotoxic Compounds Derived from Marine Sponges. A Review (2010-2012).From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers.Patient-derived xenograft models in musculoskeletal malignancies.Characterizing Cancer Drug Response and Biological Correlates: A Geometric Network Approach.Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach
P2860

NCI-60 Cell Line Screening: A Radical Departure in its Time.

Item
http://www.wikidata.org/entity/Q30383428
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
NCI-60 Cell Line Screening: A Radical Departure in its Time.
@ast
NCI-60 Cell Line Screening: A Radical Departure in its Time.
@en
type
label
NCI-60 Cell Line Screening: A Radical Departure in its Time.
@ast
NCI-60 Cell Line Screening: A Radical Departure in its Time.
@en
prefLabel
NCI-60 Cell Line Screening: A Radical Departure in its Time.
@ast
NCI-60 Cell Line Screening: A Radical Departure in its Time.
@en
P1433
P1476
P2093
P2860
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
NCI-60 Cell Line Screening: A Radical Departure in its Time.
@en
P2093
P2860
P31
P356
P407
P433
P478
P577
P698